- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | The Power of Plurality | ||
| Mi | Governor Josh Stein marks strengthening North Carolina-Ireland trade relationship at Uniphar facility visit | ||
| Mi | Gilead and PAHO announce milestone partnership to accelerate access to HIV pre-exposure treatment | ||
| Mi | Chiesi appoints David Khougazian as Group CEO | ||
| Di | When what matters to patients is hard to measure | ||
| Di | Pessimism, practice and policy: are we still making the right argument for health innovation? | ||
| Di | J&J's Darzalex combination treatment for untreated multiple myeloma recommended by NICE | ||
| Mo | AstraZeneca's Tagrisso shows eight-year landmark survival in early-stage EGFR-mutated lung cancer | ||
| Fr | AstraZeneca shares phase 3 results for Imfinzi plus Imdelltra in extensive-stage small cell lung cancer | ||
| Fr | Langland appoints Kathryn Stewart as Head of Strategy and promotes Diane Ross to Head of Scientific Practice | ||
| 10.09. | Novo Nordisk UK appoints George Godfrey as Senior Director, Medical & Regulatory | ||
| 10.09. | Roche's Enspryng gets FDA Priority Review for autoimmune disease with no approved treatments | ||
| 09.09. | Gilead opens new research centre bringing together oncology, inflammation and research data science teams | ||
| 09.09. | Abivax has appointed Ivan Nuñez-Pacheco as Abivax Global Head of Patient Services | ||
| 08.09. | AstraZenca's Etcamah combination therapy given FDA Accelerated Approval for breast cancer | ||
| 08.09. | Cell and gene therapies - moving from niche innovations towards broader clinical use | ||
| 07.09. | Abivax has appointed James Berger as Global Head of Marketing | ||
| 07.09. | FDA approves Priovant's Lisraya for dermatomyositis | ||
| 04.09. | Pfizer and BioNTech's XFG-adapted COVID-19 vaccine approved by US FDA | ||
| 04.09. | Moderna's updated COVID-19 mRNA vaccine approved by MHRA | ||
| 03.09. | Novartis announces trial results for remibrutinib in relapsing multiple sclerosis | ||
| 03.09. | Inventiva appoints Chris Benecchi as Chief Operating Officer | ||
| 02.09. | Lilly to acquire Merida Biosciences in deal worth up to $2.875bn | ||
| 02.09. | Prescient completes integration of Uptake and Dolon under single global brand | ||
| 01.09. | AstraZeneca and Daiichi Sankyo's Enhertu plus pertuzumab approved in EU as first-line treatment for breast cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.